BLIS Technologies

BLIS Technologies Limited is reporting revenue growth of 23% and ebitda of $0.5m for the first quarter, ending June 30, 2024.

Revenue for 1Q25 was $3.4m, an increase of $0.6m compared with the same period past year. Ebitda was up $0.5m on the breakeven result from 1Q24.

The biotechnology company commenced business in August 2000 when it acquired, from the University of Otago, rights to Salivaricin B, a substance that acts as a natural antibiotic to control streptococcal throat infections. Since then, it has acquired the university's collection of several thousand BLIS (bacteriocin-like-inhibitory substances) producing organisms collected over 25 years by Professor John Tagg, now a consultant to the company.

Chief executive officer Scott Johnson said the outlook for the FY25 year was double-digit revenue growth on FY24 and an ebitda result similar to last year, noting the result will include a material investment in China regulatory access of $0.5m.



Company Details

Registered Office: 399 Moray Place, Dunedin Central Dunedin 9016
Postal Address: 399 Moray Place, Dunedin Central Dunedin 9016
Telephone: +64-347-41338
Facsimile: n/a
Website: http://www.blis.co.nz/
First Listed: 30/07/2001
Balance Date: 31 March
AGM: 21/08/2025

Directors and Executives

Anita Johansen
Director
Scott Johnson
Chief Executive Officer
Aimee McCammon
Independent Director
Geoff Plunket
Chair
Barry Richardson
Independent Director
Dr Alison Stewart
Independent Director
Richard Wingham
Chief Financial Officer

Announcements

Title Date Type
2025 Annual Shareholder Meeting Results Announcement Thu, Aug 21 2025 01:44 pm MEETING
2025 Annual Meeting of Shareholders Thu, Aug 21 2025 11:00 am MEETING
Revenue growth with one off cost pressures impacting profit Mon, Aug 18 2025 08:30 am MKTUPDTE
Notice of meeting and proxy form Wed, Jul 23 2025 08:30 am MEETING
Patent issue settled and new 5 year agreement with BSP Wed, Jul 02 2025 08:30 am MKTUPDTE
2025 Annual Shareholder Meeting and Director Nominations Tue, Jun 24 2025 08:30 am MEETING
Revenue and earnings growth Thu, May 22 2025 08:30 am FLLYR
Revenue Growth and Profitable Third Quarter Fri, Feb 21 2025 08:30 am MKTUPDTE
Favourable result despite challenging economic backdrop Tue, Nov 26 2024 08:30 am HALFYR
Partnership with Chinese Distributor Fri, Nov 15 2024 02:02 pm MKTUPDTE

Major Holdings Announcements

Date Name No. Held % Current
28/02/23 Roger Norman Macassey and Mark Andr 142,213,158 - 11.16
07/07/21 Probi Aktiebolag 166,148,034 - 13.04
18/05/20 Wen Yi 53,280,077 5.83 4.81
27/03/18 W. Wu - 6.83 -
06/03/17 Edinburgh Equity Limited 31,157,388 5.59 2.81
08/02/17 Mingchun Qiu 39,000,000 5.50 3.52

Director’s Interests Announcements

Date Name No. Held % Details Other
22/03/24 Scott Johnson 5,965,860 - - -
25/03/22 Brian David Watson 4,730,431 - - -
09/03/20 Anthony Paul Offen 31,157,388 - - -
06/03/20 Alison Stewart 350,000 - - -
11/04/19 Geoffrey Phil Plunket 800,000 - - -
05/04/19 Alison Barrass 200,000 - - -
03/08/18 Barry Charles Richardso 17,903,625 - - -
01/12/16 Timothy James Mepham 55,977 0.01 - -

Analysts’ Forecasts

No forecasts available

Disclaimer

Data on this page is from BusinessDesk and NZX Ltd for information purposes only. Details are believed to be accurate but no warranty is given as to accuracy, timeliness, reliability or completeness. No person should rely on the contents of the report and all persons should obtain independent professional advice before acting on any information connected with or contained in this report.
Last Updated: 04/09/2025


Markets News

NZ stocks end flat as US Fed decision looms
Markets Market Close

NZ stocks end flat as US Fed decision looms

Market finishes slightly down as telco company Spark loses more ground.

Jamie Gray 12 Sep 2025
Markets

Locate Technologies plans to quit ASX for NZX

Bitcoin-favouring Locate Technologies eyes move to NZX's main board.

Staff reporters 12 Sep 2025
Locate Technologies plans to quit ASX for NZX
Policy

F&P Healthcare one step closer to new Karaka campus

Auckland Council has approved a request to rezone nearly 90ha going to hearings.

Oliver Lewis 12 Sep 2025
F&P Healthcare one step closer to new Karaka campus
Retail

Briscoe Group half-year splits analysts

Forsyth Barr says the stock is “quality but expensive”.

Gregor Thompson 12 Sep 2025
Briscoe Group half-year splits analysts
Markets

Spark joins global JV to sweat connectivity

Getting more value from existing networks is now the name of the game.

Pattrick Smellie 12 Sep 2025
Spark joins global JV to sweat connectivity